JAMES J BROWN

Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist JACKSON, MS NPI 1528096971

General Payments — all program years on this page

$11,561.16

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $713.28 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $713.2819

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $608.559
2019 $865.456
2020 $524.633
2021 $757.933
2022 $7,321.777
2023 $769.5522
2024 $713.2819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103377053 ABBVIE INC. $26.55 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103377055 ABBVIE INC. $16.42 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103377057 ABBVIE INC. $29.28 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104805177 Biogen, Inc. $20.59 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104807441 Biogen, Inc. $19.76 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104832080 Biogen, Inc. $22.43 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104864548 Biogen, Inc. $16.19 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114015448 Regeneron Healthcare Solutions, Inc. $3.32 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114015450 Regeneron Healthcare Solutions, Inc. $20.80 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114015452 Regeneron Healthcare Solutions, Inc. $24.97 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114015454 Regeneron Healthcare Solutions, Inc. $27.04 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114015456 Regeneron Healthcare Solutions, Inc. $123.25 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114015458 Regeneron Healthcare Solutions, Inc. $26.90 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133024381 Genentech USA, Inc. $123.78 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139300360 Astellas Pharma US Inc $19.85 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139444386 Astellas Pharma US Inc $18.42 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140357376 Bausch & Lomb Americas Inc. $24.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140357378 Bausch & Lomb Americas Inc. $24.10 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154022125 Apellis Pharmaceuticals, Inc. $125.00 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.